PTPolina Yurievna Tadjibova

Polina Yurievna Tadjibova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Polina Yurievna Tadjibova has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Mycotoxicological and genomic safety assessment of Aspergillus oryzae strain RCAM 01134 – producer of metabolites valuable for the food industry

    by Julia Alexandrovna Borshcheva, Irina Borisovna Sedova, Liubov Vyacheslavovna Rimareva, Anton Yurievich Sharikov, Polina Yurievna Tadjibova, Elena Mikhailovna Serba

    This article presents the results of a comprehensive safety study of the Aspergillus oryzae RCAM 01134 industrial strain, used in food biotechnology as a producer of acid proteinases, peptidases, and other hydrolytic enzymes. Whole-genome sequencing methods were used to perform taxonomic identification, analyze secondary metabolite biosynthesis genes (including the aflatoxin cluster), and detect allergenicity and antibiotic resistance determinants. The genome assembly comprised 37.5 million base pairs with a BUSCO completeness of 99.4%. Phylogenetic analysis of the β-tubulin gene BenA and calculation of the average nucleotide similarity (ANI 99.3%) confirmed the strain's affiliation with the species A. oryzae, closely related to A. flavus. A degraded cluster of aflatoxin biosynthesis genes with nonfunctional key genes norA, norB, and avfA (structural mutations, reading frameshifts) was identified in the genome. The absence of 11 controlled mycotoxins (aflatoxins B1, B2, G1, G2, sterigmatocystin, ochratoxin A, zearalenone, T-2 toxin, deoxynivalenol, fumonisins B1 and B2) in the culture fluid was experimentally confirmed. All values were below the detection limits (0.001–0.300 mg/kg), which is significantly below hygienic standards. Homologues of A. oryzae allergen genes (over 80% identity) were detected, characteristic of the species and posing a potential risk to sensitized individuals. Genes conferring antibiotic resistance to clinically significant drugs were absent. The authors demonstrated that deep enzymatic bioconversion of mycelial biomass using the strain's own hydrolases leads to the hydrolysis of native allergenic proteins into low-molecular-weight peptides and free amino acids (molecular weight less than 1.6 kDa), significantly reducing the allergenicity of the final products. The A. oryzae strain RCAM 01134 is recommended for industrial use in food processing as safe with respect to toxin formation, with mandatory allergenicity monitoring at the production stage and consumer information.


  • Open Access

    Microbial Biomass as a Bioresource of Functional Food Ingredients: A Review

    by Elena Serba, Tatyana Yuraskina, Liubov Rimareva, Polina Tadzibova, Elena Sokolova, Galina Volkova

    Microbial biomass is a promising source of essential macro- and micronutrients to be used in the food industry, e.g., protein, vitamins, essential amino acids, polysaccharide, etc. This article reviews scientific publications on the properties and composition of microbial biomass as a source of functional ingredients, its biological effectiveness, production methods, and composition. The review covered research articles published in 2005–2021 and indexed in eLIBRARY.RU, Google Scholar, Scopus, Elsevier, and PubMed. It relied on such general scientific methods as analysis, generalization, and systematization. Saccharomyces cerevisiae yeast and Aspergillus mycelial fungi appeared to be the most popular research objects. Most studies concentrated on the chitin-glucan-mannan complex of cell walls and protoplasmic biovaluable protein. Others featured the biocatalytic conversion of microbial polymers with the transfer of biologically valuable components into an enzyme-accessible state. Bioactive ingredients of microbial origin could be divided into sorbents, immunomodulators, neurotransmitters, antioxidants, and anticarcinogenics. Microbial fermentolysates are a potential source of bioactive compounds for functional foods. However, the medical and biological properties of their minor bioactive components remain understudied while fermentolysates can yield new functional products fortified with essential amino acids and low-molecular bioactive peptides.